VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
173 hedge funds and large institutions have $364M invested in Verve Therapeutics in 2024 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $372M → $364M (-$7.49M)
1.79% less ownership
Funds ownership: 90.65% → 88.86% (-1.8%)
65% less call options, than puts
Call options by funds: $414K | Put options by funds: $1.19M
Holders
173
Holding in Top 10
2
Calls
$414K
Puts
$1.19M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$5.29M | |
| 3 | +$4.53M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.37M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$4.17M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$10.2M | |
| 3 | -$6.09M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.54M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$5.44M |